Bench Testing Therapeutic/Indication Pairing Strategies (UG3/UH3)

This Funding Opportunity Announcement (FOA) invites applications for support of pre-clinical studies to repurpose existing experimental or FDA approved drugs or biologics (existing therapeutics) that have already begun or completed at least a Phase l trial.

The hypothesis for proposed studies

credit:


must be developed using innovative processes to identify the therapeutic/indication pair.

Examples include independent crowdsourcing strategies (e.g., http://www.ncats.nih.gov/ntu/assets/current, http://openinnovation.astrazeneca.com/, or any website that lists experimental therapies), or use of computational algorithms.

The initial UG3 award will support the development of milestone-driven rigorous, pre-clinical target engagement and/or efficacy studies.

Once UG3 pre-clinical milestones have been met, the UH3 award may be made to support clinical trial planning:
this includes complete planning, design, and preparation of the documentation necessary for implementation of Phase I and/or Phase II clinical trials for a new therapeutic use.
Related Programs

National Center for Advancing Translational Sciences

Department of Health and Human Services


Agency: National Institutes of Health

Office:

Estimated Funding: $1,542,548


Who's Eligible





Obtain Full Opportunity Text:
http://grants.nih.gov/grants/guide/pa-files/PAR-17-465.html

Additional Information of Eligibility:
Other Eligible Applicants include the following: Alaska Native and Native Hawaiian Serving Institutions; Asian American Native American Pacific Islander Serving Institutions (AANAPISISs); Eligible Agencies of the Federal Government; Faith-based or Community-based Organizations; Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); Indian/Native American Tribal Governments (Other than Federally Recognized); Non-domestic (non-U.S.) Entities (Foreign Organizations); Regional Organizations; Tribally Controlled Colleges and Universities (TCCUs) ; U. S. Territory or Possession; Non-domestic (non-U.S.) Entities (Foreign Institutions) are not eligible to apply.

Non-domestic (non-U.S.) components of U. S. Organizations are not eligible to apply.

Foreign components, as defined in the NIH Grants Policy Statement, are allowed.

Full Opportunity Web Address:


Contact:


Agency Email Description:


Agency Email:
FBOWebmaster@OD.NIH.GOV

Date Posted:
2017-08-21

Application Due Date:
2020-09-07

Archive Date:
2020-10-13


Here are the star companies that have succeeded in their corporate social responsibility (CSR) programs. The companies were gathered by Civic 50, a national initiative to survey and rank S&P 500 corporations on how they engage with the communities they serve and utilize best practices in their corporate cultures.




Nonprofit Jobs in South Carolina

  Program Director Jobs
  Executive Director Jobs
  Social Services Jobs
  Executive Director Jobs
  Substance Abuse Jobs





More Federal Domestic Assistance Programs


Special Education- Olympic Education Programs | Transition Programs for Students with Intellectual Disabilities into Higher Education | Affordable Care Act (ACA) Maternal, Infant, and Early Childhood Home Visiting Research Programs | Social Security_Disability Insurance | Crop Disaster Program |  Site Style by YAML | Grants.gov | Grants | Grants News | Sitemap | Privacy Policy


Edited by: Michael Saunders

© 2004-2024 Copyright Michael Saunders